Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Eur J Cancer ; 169: 20-31, 2022 07.
Article in English | MEDLINE | ID: mdl-35490565

ABSTRACT

BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is notorious for its poor prognosis even after curative resection. Responses to immunotherapy are rare and related to inadequate T-cell priming. We previously demonstrated the potency of allogeneic lysate-dendritic cell (DC) vaccination in a preclinical model. Here we translate this concept to patients. METHODS: In this phase I study, patients with resected PDAC were included when they demonstrated no radiologic signs of recurrence after standard-of-care treatment. Allogeneic tumour lysate-loaded autologous monocyte-derived DCs were injected at weeks 0, 2, 4 and at months 3 and 6. Objectives are feasibility, safety and immunogenicity of allogeneic tumour-DCs. The presence of tumour antigens shared between the vaccine and patient tumours was investigated. Immunological analyses were performed on peripheral blood, skin and tumour. RESULTS: Ten patients were included. DC production and administration were successful. All patients experienced a grade 1 injection-site and infusion-related reaction. Two patients experienced a grade 2 fever and 1 patient experienced a grade 3 dyspnoea. No vaccine-related serious adverse events were observed. Shared tumour antigens were found between the vaccine and patient tumours. All evaluated patients displayed a vaccine-induced response indicated by increased frequencies of Ki67+ and activated PD-1+ circulating T-cells. In addition, treatment-induced T-cell reactivity to autologous tumour of study patients was detected. Seven out of ten patients have not experienced disease recurrence or progression at a median follow-up of 25 months (15-32 months). CONCLUSION: Allogeneic tumour lysate-DC treatment is feasible, safe and induces immune reactivity to PDAC expressed antigens.


Subject(s)
Cancer Vaccines , Hematopoietic Stem Cell Transplantation , Pancreatic Neoplasms , Antigens, Neoplasm , Cancer Vaccines/adverse effects , Dendritic Cells , Humans , Immunotherapy/adverse effects , Neoplasm Recurrence, Local/drug therapy , Pancreatic Neoplasms/drug therapy , T-Lymphocytes , Pancreatic Neoplasms
2.
Cancer Immunol Immunother ; 70(2): 453-461, 2021 Feb.
Article in English | MEDLINE | ID: mdl-32808188

ABSTRACT

INTRODUCTION: Cancer stem cells (CSCs) are implicated in tumor initiation and development of metastasis. However, whether CSCs also affect the immune system is not fully understood. We investigated correlations between the PD-L1+ CSCs, changes in T-cell phenotype in metastatic and non-metastatic lymph nodes (LNs) and response to treatment. METHODS: LNs' aspirates were obtained during the EBUS/TBNA procedure of 20 NSCLC patients at different stages of the disease. CSCs and T-cell characteristics were determined by flow cytometry. RESULTS: PD-L1+ CSCs positively correlated with the percentage of Tregs, PD-1+ CD4 T cells and Tim3+ CD4+ T cells, whereas PD-L1+ CSCs were negatively correlated with CD4+ T cells and CD28+ CD4+ T cells. The percentage of PD-L1+ CSCs was higher in patients with progressive disease (PD) as compared to patients with stable disease (SD) or partial response (PR). Among T cells, only PD-1+ CD4+ T cells and Tim3+ CD4+ T-cell frequencies were higher in patients with PD as compared to patients with SD or PR. CONCLUSION: The frequency of PD-L1+ CSCs associates with an altered T-cell frequency and phenotype indicating that CSCs can affect the immune system. The higher percentage of PD-L1+ CSCs in patients with PD may confirm their resistance to conventional therapy, suggesting that CSCs may be an interesting target for immunotherapy.


Subject(s)
B7-H1 Antigen/therapeutic use , Carcinoma, Non-Small-Cell Lung/immunology , Immunotherapy/methods , Lung Neoplasms/immunology , Tumor Microenvironment/immunology , B7-H1 Antigen/pharmacology , Carcinoma, Non-Small-Cell Lung/pathology , Female , Humans , Lung Neoplasms/pathology , Lymph Nodes/pathology , Lymphatic Metastasis , Male , Neoplastic Stem Cells/pathology
3.
Clin Exp Allergy ; 47(4): 551-564, 2017 Apr.
Article in English | MEDLINE | ID: mdl-27743410

ABSTRACT

BACKGROUND: Chronic exposure to environmental triggers, such as house dust mite (HDM), drives T helper 2 (Th2) cell-mediated asthma. Recent evidence has shown that B-T cell interaction, and in particular germinal centre reactions and follicular T helper (Tfh) cells are required for the development of eosinophilic airway inflammation in HDM-driven models containing a sensitization and challenge phase. Whether B-T cell interactions are essential for pulmonary eosinophilic inflammation following chronic allergen provocation remains unknown. AIMS: In this study, we investigated the importance of B-T cell interaction in the development of eosinophilic airway inflammation and pulmonary remodelling in a chronic HDM-driven asthma model. METHODS: We exposed C57BL/6, Cd40l-/- , and Mb1-/- mice to HDM three times a week for five consecutive weeks. RESULTS: Chronic HDM exposure induced a pronounced eosinophilic allergic airway inflammation in broncho-alveolar lavage fluid (BALf) and lung tissue, associated with the formation of immunologically active inducible bronchus-associated lymphoid tissue (iBALT) in the lungs. The absence of B cells or lack of CD40L signalling did not hamper eosinophilic inflammation in the airways, although the number of Tfh and Th2 cells was substantially reduced in the lungs. Importantly, type 2 innate lymphoid cell (ILC2) numbers in BALf and lung were not affected by the absence of B cells or B-T cell interaction. Furthermore, eosinophilic airway inflammation is not sufficient to induce pulmonary remodelling and airway hyperresponsiveness. CONCLUSION AND CLINICAL RELEVANCE: From these findings, we conclude that B-T cell interaction is required for robust Tfh and Th2 cell induction, but not essential for eosinophilic airway inflammation during a chronic HDM-driven asthma model.


Subject(s)
Allergens/immunology , Asthma/immunology , Asthma/pathology , B-Lymphocytes/immunology , Cell Communication/immunology , Eosinophils/pathology , Pyroglyphidae/immunology , T-Lymphocytes/immunology , Airway Remodeling , Animals , Asthma/metabolism , B-Lymphocytes/metabolism , Biomarkers , CD40 Ligand/metabolism , Cytokines/metabolism , Disease Models, Animal , Female , Inflammation Mediators/metabolism , Leukocyte Count , Male , Mice , Mice, Knockout , Signal Transduction , T-Lymphocytes/metabolism , Th2 Cells/immunology , Th2 Cells/metabolism
5.
J Lipid Res ; 10(5): 507-14, 1969 Sep.
Article in English | MEDLINE | ID: mdl-4309190

ABSTRACT

Lipogenesis in vitro from acetate-1-(14)C was studied in human preputial skin and abdominal skin. Radioactive lipids were separated by column chromatography on Florisil and by thin-layer chromatography on silica gel. Radioactivity was incorporated chiefly into the triglyceride, sterol, and polar lipid fractions, while lesser amounts of (14)C were found in the hydrocarbon, wax, diglyceride, monoglyceride, and fatty acid fractions; labeling of steryl esters was minimal. On thin-layer chromatography, the radioactive polar lipids had mobilities similar to lysolecithin, phosphatidyl choline, phosphatidyl ethanolamine, and phosphatidic acid. The radioactive fatty acids of the different lipid fractions were separated by gas-liquid chromatography. The major (14)C-labeled acids were 16:0 and 18:0. Radioactivity was also detected in acids 14:0, 15:0, 16:1, 18:1, 18:2, 20:0, 20:1, 22:0, 24:0, 24:1, and 26:0. No radioactivity could be detected in arachidonic acid, although this fatty acid comprises 9% of the chromatographed fatty acids. The pattern of incorporated (14)C was different from the percentage mass composition of the fatty acids. Skin is therefore active in the biosynthesis of a wider variety of lipids than previously demonstrated.


Subject(s)
Acetates/metabolism , Lipids/biosynthesis , Skin/metabolism , Abdomen , Adult , Carbon Isotopes , Chromatography , Chromatography, Gas , Chromatography, Thin Layer , Fatty Acids/biosynthesis , Glycerides/biosynthesis , Humans , Hydrocarbons/biosynthesis , Infant, Newborn , Male , Penis , Silicon Dioxide , Silver Nitrate , Sterols/biosynthesis , Triglycerides/biosynthesis , Waxes/biosynthesis
7.
J Lipid Res ; 8(2): 150-2, 1967 Mar.
Article in English | MEDLINE | ID: mdl-14564724

ABSTRACT

Column and thin-layer chromatographic systems employing silver nitrate-impregnated adsorbents are described for the separation of sterol acetates which differ in the number of double bonds in the steroid nucleus or side chain.


Subject(s)
Chromatography, Thin Layer/methods , Chromatography/methods , Sterols/isolation & purification , Acetates/chemistry , Acetates/isolation & purification , Silver Nitrate , Sterols/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...